Henry Schein Inc. stock underperforms Monday when compared to competitors
Henry Schein Inc. closed 14.16% short of its 52-week high of $82.49, which the company reached on February 5th.
Notable healthcare headlines for the week: Viatris, J&J, Walgreens Boots Alliance Teladoc Health and Pfizer in focus
Discover top S&P 500 healthcare gainers & losers this week, key corporate updates, M&A news, and policy impacts shaping the healthcare sector's outlook.